Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

Retinal Disorders Clinical Trial

Official title:

Anesthesia for PPV Using Insulin Needle

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00735657
• Other study ID #: Rp0822
• Status: Completed
• Phase: N/A
• Start date: August 2008
• Est. completion date: December 2010

Study information

• Verified date: November 2021
• Source: King Khaled Eye Specialist Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.

Description:

The author wants to see the effect of short needle in patients undergoing retinal surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: December 2010
• Est. primary completion date: August 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Adult patients undergoing pars plana vitrectomy under local anesthesia

Exclusion Criteria:

• Patients allergic to local anesthetic solutions

• With local sepsis

• Serious impairment of coagulation

• Orbital abnormalities

• Unable to cooperate in maintaining a relatively motionless supine position

• Who refused the anesthetic technique

Related Conditions & MeSH terms

• Retinal Diseases
• Retinal Disorders

Intervention

Device:
• needle
Peribulbar blockade with standard (25 mm) needle
• needle
Peribulbar blockade with short (12.5 mm) needle

Procedure:
• Pars Plana Vitrectomy
Peribulbar block

Locations

Country	Name	City	State
Saudi Arabia	King Khaled Eye Specialist hospital	Riyadh

Sponsors (1)

Lead Sponsor	Collaborator
King Khaled Eye Specialist Hospital

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy of insulin needle.		1 year